Tempest Therapeutics (TPST) Times Interest Earned (2012 - 2025)
Tempest Therapeutics (TPST) posted Times Interest Earned of -$0.33 for Q3 2025, up 89.13% sequentially from -$3.07 in Q2 2025, and up 98.96% YoY from -$0.17 in Q3 2024.
Tempest Therapeutics (TPST) Times Interest Earned (2012 - 2025) Analysis & Trends
Tempest Therapeutics has reported Times Interest Earned for 14 years, with the latest figure at -$0.33 in Q3 2025.
- Quarterly Times Interest Earned rose 98.96% year-over-year to -$0.33 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$37.27 (down 14.59% YoY) and the FY2025 annual result came in at -$12.02, down 4958.74% from the prior year.
- Times Interest Earned improved to -$0.33 in Q3 2025 per TPST's latest filing, from -$3.07 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.33 in Q3 2025 and troughed at -$67.93 in Q1 2025.
- A 5-year average of -$23.08 and a median of -$20.98 in 2023 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2021 and 2025: Times Interest Earned plunged 621.35% in 2021, then soared 98.96% in 2025.
- Over 5 years, Times Interest Earned stood at -$21.71 in 2021, then increased by 4.74% to -$20.68 in 2022, then advanced by 3.62% to -$19.93 in 2023, then slumped by 213.14% to -$62.41 in 2024, then soared by 99.47% to -$0.33 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$0.33, -$3.07, and -$67.93 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Tempest Therapeutics | 4.32 Mn | 3.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -271.80 |
| Sep 30, 2025 | -0.33 |
| Jun 30, 2025 | -3.07 |
| Mar 31, 2025 | -67.93 |
| Dec 31, 2024 | -62.41 |
| Sep 30, 2024 | -32.07 |
| Jun 30, 2024 | -25.76 |
| Mar 31, 2024 | -21.67 |
| Dec 31, 2023 | -19.93 |
| Sep 30, 2023 | -17.67 |
| Jun 30, 2023 | -20.98 |
| Mar 31, 2023 | -21.60 |
| Dec 31, 2022 | -20.68 |
| Sep 30, 2022 | -17.94 |
| Jun 30, 2022 | -16.74 |
| Mar 31, 2022 | -11.79 |
| Dec 31, 2021 | -21.71 |
| Sep 30, 2021 | -9.43 |
| Jun 30, 2021 | -24.58 |
| Mar 31, 2021 | -22.19 |